Pages that link to "Q39427001"

The following pages link to Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive (Q39427001):

Displaying 38 items.

• Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine (Q21134724) (← links)
• Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs (Q26782083) (← links)
• Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans (Q28741103) (← links)
• Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality (Q28744027) (← links)
• Adenoviruses in lymphocytes of the human gastro-intestinal tract (Q28744382) (← links)
• Adenoviral vectors as novel vaccines for influenza. (Q30370445) (← links)
• Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform (Q30422006) (← links)
• Protection of non-human primates against rabies with an adenovirus recombinant vaccine (Q33684288) (← links)
• Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial. (Q33875160) (← links)
• Comparison of Human Memory CD8 T Cell Responses to Adenoviral Early and Late Proteins in Peripheral Blood and Lymphoid Tissue (Q33921073) (← links)
• Adenovirus infections in immunocompetent and immunocompromised patients (Q34057627) (← links)
• Infection with host-range mutant adenovirus 5 suppresses innate immunity and induces systemic CD4 T cell activation in rhesus macaques (Q34155550) (← links)
• Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae (Q34178208) (← links)
• Reconstitution of huPBL-NSG mice with donor-matched dendritic cells enables antigen-specific T-cell activation (Q34525894) (← links)
• Suppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome. (Q35184207) (← links)
• Induction and comparison of SIV immunity in Ad5 naïve and Ad5 immune non-human primates using an Ad5 [E1-, E2b-] based vaccine (Q35317858) (← links)
• Immunology. Immune activation with HIV vaccines (Q35551760) (← links)
• A serological survey of human adenovirus serotype 2 and 5 circulating pediatric populations in Changchun, China, 2011 (Q36448142) (← links)
• Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001). (Q36495587) (← links)
• T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV/NDK challenge virus load (Q37693810) (← links)
• Optimizing vaccine-induced CD8( ) T-cell immunity: focus on recombinant adenovirus vectors (Q37932525) (← links)
• Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo (Q37996192) (← links)
• Immune recognition of gene transfer vectors: focus on adenovirus as a paradigm (Q38008337) (← links)
• Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials. (Q38096490) (← links)
• Diagnosis and treatment of adenovirus infection in immunocompromised patients (Q38145327) (← links)
• Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?. (Q38284700) (← links)
• Progress on adenovirus-vectored universal influenza vaccines (Q38421971) (← links)
• Immunogenicity when utilizing adenovirus serotype 4 and 5 vaccines expressing circumsporozoite protein in naïve and adenovirus (Ad5) immune mice. (Q39598811) (← links)
• Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension (Q40106073) (← links)
• Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection (Q41335764) (← links)
• Can Viruses be Modified to Achieve Sustained Gene Transfer (Q42154256) (← links)
• Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane (Q47607706) (← links)
• Fas activity mediates airway inflammation during mouse adenovirus type 1 respiratory infection (Q59358622) (← links)
• Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens (Q64374626) (← links)
• Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections. (Q78177467) (← links)
• Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children (Q91786395) (← links)
• Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model (Q92376584) (← links)
• Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans (Q100751547) (← links)